Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
September, 2024
September 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« Aug
vivek subbiah
Mar 8, 2024, 22:36 |
Blog
Vivek Subbiah: 'Far and away the best prize that life offers is the chance to work hard at work worth doing' — Theodore Roosevelt
Vivek Subbiah recently shared on LinkedIn: “'Far and away the best prize that life offers is…
Mar 8, 2024, 19:56 |
Insight
Vivek Subbiah: How can we Modernize Precision Oncology With Decentralized Trial Tools?
Vivek Subbiah recently shared on LinkedIn: "Precision oncology has seen exciting developments in recent years with…
Mar 8, 2024, 15:14 |
Blog
Vivek Subbiah: Harnessing the potential of basket trials
Vivek Subbiah recently shared a post on X/Twitter: "Revolutionizing cancer drug development: Harnessing the potential…
Mar 7, 2024, 17:07 |
Blog
Vivek Subbiah: It was such a delight to be at the Precision Oncology WIN Symposium 2024
Vivek Subbiah shared a post on X: "It was such a delight to be at the…
Mar 3, 2024, 16:42 |
Blog
Vivek Subbiah: Thrilled to announce a groundbreaking - AstraZeneca and Sarah Cannon Docs collaboration
Vivek Subbiah shared a post on X: "Exciting News in Clinical Trials! Thrilled to announce…
Mar 2, 2024, 23:07 |
Blog
Vivek Subbiah: Such an honor to be invited to the WIN symposium, Abu Dhabi, UAE
Vivek Subbiah recently shared on X: “Announcement: Tumor-Agnostic Precision Oncology goes global Such an honor…
Feb 23, 2024, 18:03 |
Blog
Vivek Subbiah: The development of armored CAR T-cells may enable CAR T to be efficacious against a broader range of malignancies
Vivek Subbiah recently shared on LinkedIn: "'CARs are sharpening their weapons'. The development of armored…
Feb 22, 2024, 23:12 |
Blog
Vivek Subbiah: A look at breakthrough treatment for sickle cell anemia
Vivek Subbiah shared on X: “Jimi and Victoria met in person for the first time…
Feb 21, 2024, 18:18 |
Insight
Vivek Subbiah: As of December 31, 2023, the FDA had become aware of 22 cases of T-cell cancers that occurred after treatment with CAR-T products
Vivek Subbiah shared on LinkedIn: "Perspective article on 'Secondary Cancers after Chimeric Antigen Receptor T-Cell…
Feb 20, 2024, 18:51 |
Blog
Vivek Subbiah: Our editorial comments on the ASCO TAPUR study spearheaded by the amazing Richard Schilsky
Vivek Subbiah recently shared on X/Twitter: "Hot off the press Pleased to share our editorial…
15
16
17
18
19
All:
340
Posts:
161 - 170
Top 100 Xfluencers in Pediatric Hematology/Oncology: Key Opinion Leaders to follow on X (Twitter) in 2024
Jeff Bridges and Lymphoma: How He Went Against, How He Survived, and More
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 5
Familial Adenomatous Polyposis: Alarming Symptoms, Causes, Types, Diagnosis and Treatment
OncoDaily Party Barcelona
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube